News Category
Lantern Pharma's Q2 2026 results highlight AI-driven pipeline progress, including promising LP-300 data and the spin-off of Open Medicine AI, undersco...
Lantern Pharma's upcoming webcast will detail its Q2 2026 financial results and provide critical updates on its AI platforms and clinical pipeline, un...
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for LP-184 therapy, advancing p...
Formycon AG and OneSource Specialty Pharma have announced a strategic partnership for biosimilar manufacturing, leveraging OneSource's integrated Drug...
Lantern Pharma's launch of ZetaOmics, an AI-driven computational biology platform, aims to streamline multi-omic analysis and expand its commercial re...
Academy Hunt has expanded its platform to include over 1,000 comparisons of AI, machine learning, and data science courses across India, helping stude...
Quantum Genesis AI Corp. issues a clarification to distinguish its research activities from those of Quantumzyme LLP, reaffirming its ownership of key...
Lanterna Pharma raised $4.4 million through a registered direct offering and concurrent private placement, providing capital to advance its AI-powered...
Lantern Pharma announced the expansion of its predictBBB platform into a Large Quantitative Model, providing a real-time web-based molecular intellige...
Lantern Pharma will host its first live public demonstration of its withZeta.ai multi-agentic AI co-scientist platform on April 30, 2026, highlighting...
